Skip to content
April 27, 2023

Antiva Biosciences

Antiva

Antiva is developing novel topical therapies to treat pre-cancerous cervical lesions as well as the HPV infections that cause these lesions.

 

You are about to leave MPM BioImpact's website. MPM BioImpact is not responsible for the content on other companies' websites.

Cancel Continue